Health-care Disruptors: New Models Changing the Landscape

Details
Watch Next

Details

Traditional models of medical product research and development and health-care delivery are being disrupted, as incentives for research and care shift and technology opens up new opportunities. Hospitals and universities are shaking up conventional approaches to their roles. New investment models are emerging for financing early-stage R&D all the way to product approval and access. What is behind these transformations, and what will the health-care and research landscape look like for patients and investors over the next few years?

Custom Author Text

Moderator

Casey Ross National Technology Correspondent, STAT

Speakers

Ray Dorsey David M. Levy Professor of Neurology, University of Rochester

Joel Dudley Associate Professor of Genetics and Genomic Sciences and Founding Director of the Institute for Next Generation Healthcare, Icahn School of Medicine, Mount Sinai

Andrea Feinberg Chief Health Officer, Geisinger Innovation

Dan Liljenquist Senior Vice President and Chief Strategy Officer, Intermountain Healthcare

Supporting and Strengthening Minority-Owned Businesses During (and After) the Pandemic

143 views

The Long-Term Care Crisis: Exploring Innovative Financing and Delivery Strategies

178 views

In Search for a Cure: Are We Nearing a Treatment for COVID-19?

101 views

The Impact Revolution - Conference Call Series

87 views

Health-care Disruptors: New Models Changing the Landscape

Watch Next

21st Century Medicine: Are We There Yet?

A Conversation with Elizabeth Blackburn

A Conversation with FDA Commissioner Scott Gottlieb

A Conversation with FDA Commissioner Stephen Hahn